EligibleTrials

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

Recruiting · NCT05181826 · Observational (researchers observe without assigning treatment) · Lead sponsor: Helio Genomics

View the official record on ClinicalTrials.gov →
Lung cancerHepatitis BCOPD

Interventions studied

Multi-analyte Blood Test

What this trial is about

To acquire blood samples from subjects for various purposes, including: i) determining the sensitivity and specificity of select DNA methylation markers for the detection of various types of cancer, ii) identifying benign conditions that may induce false positive or false negative results, and iii) defining the effects of potential interfering substances, such as chemotherapy drugs.

Who can take part

Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)

Inclusion criteria

Exclusion criteria

Where it is running

7 locations listed across 4 US states.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.